From: The oncoprotein TBX3 is controlling severity in experimental arthritis
Disease parameter (phenotype) | Experimental group | |||||
---|---|---|---|---|---|---|
Eae39r congenic (n = 11) | Littermate controls (n = 15) | p valuea | Eae39r2 sub-congenic (n = 10) | Littermate controls (n = 19) | p valuea | |
Incidence | 9/11 (82%) | 8/15 (53%) | 0.2167 | 10/10 (100%) | 15/19 (79%) | 0.2680 |
Mean max scoreb | 9.7 ± 1.6 | 3.9 ± 1.3 | 0.0041** | 8.30 ± 1.14 | 4.4 ± 0.8 | 0.0118* |
AUCc | 80.8 ± 18 | 29.7 ± 11.2 | 0.0120* | 67.8 ± 17.6 | 25.7 ± 7.2 | 0.0134* |
Mean day of disease onset | 42.2 ± 2.6 | 36.3 ± 3.4 | 0.1942 | 47.9 ± 3.4 | 53.6 ± 2.9 | 0.2529 |
Number of mice euthanizedd | 7/11 (64%) | 3/15 (20%) | 0.0426* | 5/10 (50%) | 2/19 (10.5%) | 0.0302* |